Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Bacillus licheniformis-Fermented Products Reduce Diarrhea Incidence and Alter the Fecal Microbiota Community in Weaning Piglets.

Hung DY, Cheng YH, Chen WJ, Hua KF, Pietruszka A, Dybus A, Lin CS, Yu YH.

Animals (Basel). 2019 Dec 13;9(12). pii: E1145. doi: 10.3390/ani9121145.

2.

Contextual Conditions and Performance Improvement in Primary Care.

Hung DY, Harrison MI, Liang SY, Truong QA.

Qual Manag Health Care. 2019 Apr/Jun;28(2):70-77. doi: 10.1097/QMH.0000000000000198.

PMID:
30921280
3.

Sustainment of Lean Redesigns for Primary Care Teams.

Hung DY, Gray CP, Truong QA, Harrison MI.

Qual Manag Health Care. 2019 Jan/Mar;28(1):15-24. doi: 10.1097/QMH.0000000000000200.

PMID:
30586118
4.

Nurses' Perspectives on Lean Redesigns to Patient Flow and Inpatient Discharge Process Efficiency.

Nicosia FM, Park LG, Gray CP, Yakir MJ, Hung DY.

Glob Qual Nurs Res. 2018 Nov 20;5:2333393618810658. doi: 10.1177/2333393618810658. eCollection 2018 Jan-Dec.

5.

Physician Engagement With Metrics in Lean Primary Care Transformation.

Gray CP, Yakir M, Hung DY.

Qual Manag Health Care. 2018 Jul/Sep;27(3):117-122. doi: 10.1097/QMH.0000000000000182.

PMID:
29944622
6.

Experiences of primary care physicians and staff following lean workflow redesign.

Hung DY, Harrison MI, Truong Q, Du X.

BMC Health Serv Res. 2018 Apr 10;18(1):274. doi: 10.1186/s12913-018-3062-5.

7.

Scaling Lean in primary care: impacts on system performance.

Hung DY, Harrison MI, Martinez MC, Luft HS.

Am J Manag Care. 2017 Mar;23(3):161-168.

8.

Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.

Tom MR, Li J, Ueno A, Fort Gasia M, Chan R, Hung DY, Chenoo S, Iacucci M, Jijon HB, Kaplan GG, Beck PL, Panaccione R, Barkema HW, Buret AG, Yajnik V, Ghosh S.

Inflamm Bowel Dis. 2016 Jul;22(7):1596-608. doi: 10.1097/MIB.0000000000000848.

PMID:
27306067
9.

Shared Medical Appointments: A Promising Innovation to Improve Patient Engagement and Ease the Primary Care Provider Shortage.

Stults CD, McCuistion MH, Frosch DL, Hung DY, Cheng PH, Tai-Seale M.

Popul Health Manag. 2016 Feb;19(1):11-6. doi: 10.1089/pop.2015.0008. Epub 2015 Jun 19.

PMID:
26090793
10.

Leveraging electronic health records to develop measurements for processes of care.

Tai-Seale M, Wilson CJ, Panattoni L, Kohli N, Stone A, Hung DY, Chung S.

Health Serv Res. 2014 Apr;49(2):628-44. doi: 10.1111/1475-6773.12126. Epub 2013 Nov 18.

11.

Overcoming challenges to adoption of shared medical appointments.

McCuistion MH, Stults CD, Dohan D, Frosch DL, Hung DY, Tai-Seale M.

Popul Health Manag. 2014 Apr;17(2):100-5. doi: 10.1089/pop.2013.0035. Epub 2013 Oct 24.

PMID:
24156662
12.

Recognition as a patient-centered medical home: fundamental or incidental?

Dohan D, McCuistion MH, Frosch DL, Hung DY, Tai-Seale M.

Ann Fam Med. 2013 May-Jun;11 Suppl 1:S14-8. doi: 10.1370/afm.1488.

13.

What's in a setting?: Influence of organizational culture on provider adherence to clinical guidelines for treating tobacco use.

Hung DY, Leidig R, Shelley DR.

Health Care Manage Rev. 2014 Apr-Jun;39(2):154-63. doi: 10.1097/HMR.0b013e3182914d11.

PMID:
23636103
14.

Paying for prevention: associations between pay for performance and cessation counseling in primary care practices.

Hung DY, Green LA.

Am J Health Promot. 2012 Mar-Apr;26(4):230-4. doi: 10.4278/ajhp.091118-QUAN-368.

PMID:
22375573
15.

Assessing the impact of behavioral risk factors and known-groups validity of the SF-12 in a US Chinese immigrant population.

Hung DY, Lubetkin EI, Fahs MC, Shelley DR.

Med Care. 2009 Feb;47(2):262-7. doi: 10.1097/MLR.0b013e3181844de4.

16.

Common measures, better outcomes (COMBO): a field test of brief health behavior measures in primary care.

Fernald DH, Froshaug DB, Dickinson LM, Balasubramanian BA, Dodoo MS, Holtrop JS, Hung DY, Glasgow RE, Niebauer LJ, Green LA.

Am J Prev Med. 2008 Nov;35(5 Suppl):S414-22. doi: 10.1016/j.amepre.2008.08.006.

PMID:
18929989
17.

Practice-level approaches for behavioral counseling and patient health behaviors.

Balasubramanian BA, Cohen DJ, Clark EC, Isaacson NF, Hung DY, Dickinson LM, Fernald DH, Green LA, Crabtree BF.

Am J Prev Med. 2008 Nov;35(5 Suppl):S407-13. doi: 10.1016/j.amepre.2008.08.004.

PMID:
18929988
18.

The chronic care model and relationships to patient health status and health-related quality of life.

Hung DY, Glasgow RE, Dickinson LM, Froshaug DB, Fernald DH, Balasubramanian BA, Green LA.

Am J Prev Med. 2008 Nov;35(5 Suppl):S398-406. doi: 10.1016/j.amepre.2008.08.009.

PMID:
18929987
19.

Multilevel analysis of the chronic care model and 5A services for treating tobacco use in urban primary care clinics.

Hung DY, Shelley DR.

Health Serv Res. 2009 Feb;44(1):103-27. doi: 10.1111/j.1475-6773.2008.00896.x. Epub 2008 Sep 8.

20.

Kinetic analysis of saturable hepatic uptake of digoxin and its inhibition by rifampicin.

Weiss M, Hung DY, Poenicke K, Roberts MS.

Eur J Pharm Sci. 2008 Aug 7;34(4-5):345-50. doi: 10.1016/j.ejps.2008.05.007. Epub 2008 Jun 3.

PMID:
18573335
21.

Improving the delivery of preventive care services.

Hung DY.

Manag Care Interface. 2007 May;20(5):38-44.

PMID:
17626591
22.

Rethinking prevention in primary care: applying the chronic care model to address health risk behaviors.

Hung DY, Rundall TG, Tallia AF, Cohen DJ, Halpin HA, Crabtree BF.

Milbank Q. 2007;85(1):69-91.

23.

Physiologically based synthetic models of hepatic disposition.

Hunt CA, Ropella GE, Yan L, Hung DY, Roberts MS.

J Pharmacokinet Pharmacodyn. 2006 Dec;33(6):737-72. Epub 2006 Oct 19.

24.

Productivity and turnover in PCPs: the role of staff participation in decision-making.

Hung DY, Rundall TG, Cohen DJ, Tallia AF, Crabtree BF.

Med Care. 2006 Oct;44(10):946-51.

PMID:
17001266
25.

Influence of primary care practice and provider attributes on preventive service delivery.

Hung DY, Rundall TG, Crabtree BF, Tallia AF, Cohen DJ, Halpin HA.

Am J Prev Med. 2006 May;30(5):413-22.

PMID:
16627129
26.

Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation.

Hung DY, Siebert GA, Chang P, Whitehouse MW, Fletcher L, Crawford DH, Roberts MS.

Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G343-51. Epub 2005 Sep 15.

27.

Therapeutic effects and possible mechanisms of a snake venom preparation in the fibrotic rat liver.

Chang P, Hung DY, Siebert GA, Bridle K, Roberts MS.

Dig Dis Sci. 2005 Apr;50(4):745-52.

PMID:
15844712
28.

Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver.

Hung DY, Siebert GA, Chang P, Roberts MS.

Br J Pharmacol. 2005 May;145(1):57-65.

29.

Reduced hepatic extraction of palmitate in steatosis correlated to lower level of liver fatty acid binding protein.

Hung DY, Siebert GA, Chang P, Burczynski FJ, Roberts MS.

Am J Physiol Gastrointest Liver Physiol. 2005 Jan;288(1):G93-100. Epub 2004 Sep 2.

30.

Disposition kinetics of propranolol isomers in the perfused rat liver.

Hung DY, Siebert GA, Chang P, Anissimov YG, Roberts MS.

J Pharmacol Exp Ther. 2004 Nov;311(2):822-9. Epub 2004 Jun 10.

PMID:
15192084
31.

Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.

Siebert GA, Hung DY, Chang P, Roberts MS.

J Pharmacol Exp Ther. 2004 Jan;308(1):228-35. Epub 2003 Oct 17.

PMID:
14566005
32.

Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites.

Hung DY, Burczynski FJ, Chang P, Lewis A, Masci PP, Siebert GA, Anissimov YG, Roberts MS.

Am J Physiol Gastrointest Liver Physiol. 2003 Mar;284(3):G423-33. Epub 2002 Nov 20.

33.

Quantitative evaluation of altered hepatic spaces and membrane transport in fibrotic rat liver.

Hung DY, Chang P, Cheung K, Winterford C, Roberts MS.

Hepatology. 2002 Nov;36(5):1180-9.

PMID:
12395328
34.

A signal transduction protein cues proteolytic events critical to Caulobacter cell cycle progression.

Hung DY, Shapiro L.

Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13160-5. Epub 2002 Sep 17.

35.

Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity, and nature of drug.

Hung DY, Chang P, Cheung K, McWhinney B, Masci PP, Weiss M, Roberts MS.

J Pharmacol Exp Ther. 2002 Jun;301(3):1079-87.

PMID:
12023540
36.

A homolog of the CtrA cell cycle regulator is present and essential in Sinorhizobium meliloti.

Barnett MJ, Hung DY, Reisenauer A, Shapiro L, Long SR.

J Bacteriol. 2001 May;183(10):3204-10.

37.
38.

Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver.

Weiss M, Kuhlmann O, Hung DY, Roberts MS.

Br J Pharmacol. 2000 Jul;130(6):1331-8.

39.

Focused antithrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats.

Hung DY, Mellick GD, Masci PP, Whitaker AN, Whitehouse MW, Roberts MS.

J Lab Clin Med. 1998 Dec;132(6):469-77.

PMID:
9851736
40.
41.

Hepatic disposition and metabolite kinetics of a homologous series of diflunisal esters.

Hung DY, Mellick GD, Anissimov YG, Weiss M, Roberts MS.

J Pharm Sci. 1998 Aug;87(8):943-51.

PMID:
9687338
42.

The effect of protein binding on the hepatic first pass of O-acyl salicylate derivatives in the rat.

Hung DY, Mellick GD, Whitehead BD, Roberts MS.

J Pharm Pharmacol. 1998 Jan;50(1):63-9.

PMID:
9504436

Supplemental Content

Support Center